A carregar...
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
INTRODUCTION: Synaptic dysfunction and degeneration is one of the earliest events in Alzheimer's disease (AD) and the best correlate of cognitive decline. Thus, identification and validation of biomarkers reflecting synaptic degeneration to be used as prognostic biomarkers are greatly needed. M...
Na minha lista:
| Publicado no: | Alzheimers Dement (Amst) |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087978/ https://ncbi.nlm.nih.gov/pubmed/33969172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12179 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|